Journal
AMERICAN JOURNAL OF SURGERY
Volume 193, Issue 5, Pages 614-617Publisher
EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC
DOI: 10.1016/j.amjsurg.2007.01.002
Keywords
esophageal cancer; neoadjuvant chemoradiation; pathologic complete response; staging
Categories
Ask authors/readers for more resources
Background: Although a substantial proportion of patients undergoing neoadjuvant chemoradiation for invasive esophageal cancer develop a pathologic complete response (pCR), these patients nonetheless have a poor 5-year survival rate. We hypothesized that routine pathologic examination fails to identify some residual cancer. Methods: Patients undergoing esophagectomy for cancer at 2 tertiary care centers were identified. Archived tumor blocks were retrieved for patients with pCR, sectioned at 50-mu m intervals and reexamined for residual cancer. Results: Seventy patients underwent neoadjuvant chemoradiation. Tumor blocks were available for 23 of 2 6 complete responders. A total of 159 blocks were reexamined. One patient was found to have a possible focus of residual invasive adenocarcinoma versus high-grade dysplasia. The remaining 22 patients had no residual disease. Conclusions: A more aggressive examination protocol for postchemoradiation esophagectomy specimens may not result in significant upstaging. Inadequate pathologic examination is likely not a major factor in the suboptimal survival in patients with pCR. (c) 2007 Excerpta Medica Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available